Literature DB >> 7058703

Immunological monitoring of patients affected by anaplastic glioma concerning in effects of surgery, radio-, and chemotherapy. A preliminary report.

F Servadei, R Parente, F Spagnolli, G Gaist, R Padovani, M Bucci, L Steiner.   

Abstract

The authors studied 24 patients affected by anaplastic gliomas, as regards immunology. In all of them the authors evaluated the lymphocyte subpopulation (B and T), firstly by simple lymphocyte count, secondly by studying the rosettes E-total and EAC, thirdly by stimulating the lymphocytes with mitogens phyto-haemoagglutinin-P (PHA), concanavalin A (Con A), and pokeweed mitogen (PWM), and lastly by counting the release of Cr51 in Chang liver cells culture in order to obtain antibody dependent cellular cytotoxicity (ADCC). The parameters were also evaluated after surgery and during conventional radio-chemotherapy with BCNU. Whereas the so-called B-pool seems to be unaffected, the preliminary results show that the T-pool (identified by the E-t rosettes and by responses to PHA, PWM, and ConA) is depressed to a statistically significant degree, if compared with a control group. This depression seems to be related to the tumoral mass, and it is not increased by radio-chemotherapy. In addition, ADCC also seems to be depressed in our glioma patients in comparison with a control group and witha group of bladder cancer patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7058703     DOI: 10.1007/bf01401752

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  30 in total

Review 1.  Immunologic aspects of cancer chemotherapy.

Authors:  C M Haskell
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

2.  Separation of leukocytes from blood and bone marrow. Introduction.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  The effects of therapeutic irradiation on lymphocytes and immunity.

Authors:  S E Order
Journal:  Cancer       Date:  1977-02       Impact factor: 6.860

4.  Letter: Impaired cell-mediated immunity in human brain tumours.

Authors:  D G Thomas; C B Lannigan; P O Behan
Journal:  Lancet       Date:  1975-06-21       Impact factor: 79.321

Review 5.  The effects of combined radiation therapy and chemotherapy on the immune response.

Authors:  A M Markoe
Journal:  Prog Exp Tumor Res       Date:  1980

6.  Immunobiology of primary intracranial tumors. Part 4: levamisole as an immune stimulant in patients and in the ASV glioma model.

Authors:  M S Mahaley; P Steinbok; P Aronin; L Dudka; D Zinn
Journal:  J Neurosurg       Date:  1981-02       Impact factor: 5.115

7.  Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients.

Authors:  M S Mahaley; W H Brooks; T L Roszman; D D Bigner; L Dudka; S Richardson
Journal:  J Neurosurg       Date:  1977-04       Impact factor: 5.115

8.  Immunobiology of primary intracranial tumours. II. Analysis of lymphocyte subpopulations in patients with primary brain tumours.

Authors:  W H Brooks; T L Roszman; M S Mahaley; R E Woosley
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

9.  Immunobiology of primary intracranial tumors. Part 5: Correlation of a lymphocyte index and clinical status.

Authors:  W H Brooks; R B Latta; M S Mahaley; T L Roszman; L Dudka; C Skaggs
Journal:  J Neurosurg       Date:  1981-03       Impact factor: 5.115

10.  Immunobiology of primary intracranial tumours. III. Demonstration of a qualitative lymphocyte abnormality in patients with primary brain tumours.

Authors:  T L Roszman; W H Brooks
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

View more
  3 in total

1.  Lymphocyte subsets in patients with brain tumors.

Authors:  M Uegaki; S Kobayashi; S Kuramoto; M M Yokoyama
Journal:  J Neurooncol       Date:  1988       Impact factor: 4.130

2.  Cellular immunity and complement levels in hosts with brain tumours.

Authors:  M Matsutani; T Suzuki; T Hori; H Terao; K Takakura; K Nishioka
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

3.  Particular features of cell-mediated immunity in patients with anaplastic gliomas. A comparison with kidney and bladder cancer patients.

Authors:  F Servadei; R Parente; M Bucci; E Beltrandi; F Tognetti; G Gaist
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.